CADASIL Test
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen
Center for Human Genetics - University of Regensburg, Hehr Laboratory - Regensburg, Germany |
CADASIL (sequence analysis of NOTCH3 gene)
method(s): ◦ Sequencing, Next Gen
CGC Genetics - Porto, Portugal |
CADASIL Test
method(s): ◦ Sequencing, Capillary (Sanger)
bio.logis Center for Human Genetics - Frankfurt am Main, Germany |
Cerebral Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Test
method(s): ◦ Sequencing, Capillary (Sanger)
General University Hospital in Prague, Institute of Inherited Metabolic Disorders - Praha, Czech Republic |
CADASIL Test
method(s): ◦ Sequencing, Capillary (Sanger)
London Health Sciences Centre, Molecular Diagnostic Laboratory - London, Ontario, Canada |
CADASIL test
method(s): ◦ Mutation Scanning of Select Exons ◦ Sequencing, Capillary (Sanger)
Medical Genetics Center, Asan Medical Center - Seoul, Korea, Republic of |
Cadasil Disease (Exon 3, 4, 5, 6)
method(s): ◦ Sequencing, Capillary (Sanger)
Biyolojik Bilimler Arastirma Gelistirme ve Uretim AS, Duzen Laboratuvarlar Grubu - Istanbul, Turkey |
CADASIL
method(s): ◦ Sequencing, Capillary (Sanger)
MVZ Dortmund Dr. Eberhard and Partner - Dortmund, Germany |
Sanger sequencing of the NOTCH3 gene
method(s): ◦ Mutation Scanning of Entire Coding Region ◦ Sequencing, Capillary (Sanger)
Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain |
Mutations in exons 2, 3 and 4 of the NOTCH3 gene
method(s): ◦ Sequencing, Capillary (Sanger) ◦ Mutation Scanning of Select Exons
Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain |
Mutations in exons 5, 6 and 11 of the NOTCH3 gene
method(s): ◦ Sequencing, Capillary (Sanger) ◦ Mutation Scanning of Select Exons
Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain |
NGS of 38 genes: ABCD1, ARSA,ASPA,CSF1R,EIF2B1 ,EIF2B2,EIF2B3,EIF2B4,EIF2B5,FAM126A,GALC,GFAP, GJ C2,HSPD1,MLC1,NOTCH3,PEX1,PEX2,PEX3,PEX5,PEX6,PEX7 ,PEX10,PEX12,PEX13,PEX14, PEX26,PLP1,POLR3A,PSAP,R NASEH2A,RNASEH2B,RNASEH2C,SAMHD1,SDHA,SOX10,SUMF1, TREX
method(s): ◦ Mutation Scanning of Entire Coding Region ◦ Sequencing, Next Gen
Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain |
epiSEEK® Comprehensive Sequence Analysis for Epilepsy and Seizure Disorders
method(s): ◦ Sequencing, Next Gen
Courtagen Life Sciences, Courtagen Diagnostics Laboratory - Woburn, MA, USA |
CADASIL Syndrome, Sequencing Exons (3-4) NOTCH 3 Gene
method(s): ◦ Mutation Scanning of Select Exons
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
CADASIL Syndrome, Sequencing Exons (2,5,6,11) NOTCH 3 Gene
method(s): ◦ Mutation Scanning of Select Exons
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
CADASIL Syndrome, Sequencing NOTCH3 Gene
method(s): ◦ Sequencing, Capillary (Sanger)
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Familial Hemiplegic Migraine , Panel Massive Sequencing (NGS) 6 Genes
method(s): ◦ Sequencing, Next Gen
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Neurodegenerative Diseases Panel
method(s): ◦ Sequencing, Next Gen
Genomic Laboratory of the DNA Research Center LTD (Centrum Badań DNA sp z o.o.) - Poznań, Poland |
Brain Development Disorders Panel
method(s): ◦ Sequencing, Next Gen
Genomic Laboratory of the DNA Research Center LTD (Centrum Badań DNA sp z o.o.) - Poznań, Poland |
Ion Channel Disorders Panel
method(s): ◦ Sequencing, Next Gen
Genomic Laboratory of the DNA Research Center LTD (Centrum Badań DNA sp z o.o.) - Poznań, Poland |
Epilepsy Panel
method(s): ◦ Sequencing, Next Gen
Genomic Laboratory of the DNA Research Center LTD (Centrum Badań DNA sp z o.o.) - Poznań, Poland |
CADASIL (sequence analysis of exons 2 to 6 and 11 of NOTCH3 gene)
method(s): ◦ Sequencing, Capillary (Sanger)
CGC Genetics - Porto, Portugal |
CADASIL (sequence analysis of exons 1, 7-10, 12-33 of NOTCH3 gene)
method(s): ◦ Sequencing, Next Gen
CGC Genetics - Porto, Portugal |
Migraine
method(s): ◦ Sequencing, Next Gen
GENETAQ, Molecular Genetics Centre - Malaga, Spain |
CADASIL Test
method(s): ◦ Sequencing, Capillary (Sanger)
Burc Molecular Genetics Laboratory - Istanbul, Turkey |
CADASIL
method(s): ◦ Sequencing, Capillary (Sanger)
L.E.S. Mikrogen Genetic Diagnosis Center - Ankara, Turkey |
CADASIL [Cerebral Arteriopathy, Autosomal Dominant, with Subcortical Infarcts and Leukoencephalopathy
method(s): ◦ Sequencing, Capillary (Sanger)
South West Thames Genetics Laboratory, St George's University of London - London, United Kingdom |
TAT: 2-4 weeks
price: $990.00
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy (CADASIL)
method(s): ◦ Sequencing, Next Gen
Connective Tissue Gene Tests - Allentown, PA, USA |
CADASIL syndrome (NOTCH3 sequencing)
method(s): ◦ Sequencing, Capillary (Sanger)
Cidegen, SL - Salamanca, Spain |
CADASIL Syndrome, Deletions-Duplications (MLPA) NOTCH3 Gene
method(s): ◦ Del/Dup (CNV)
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Teenager Stroke / Stroke-Like Episodes
method(s): ◦ Sequencing, Next Gen
MGZ München, Medizinisch Genetisches Zentrum München - München, Germany |
Brain Malformations / Neuronal Migration Disorders
method(s): ◦ Sequencing, Next Gen
MGZ München, Medizinisch Genetisches Zentrum München - München, Germany |
NOTCH3
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen
MGZ München, Medizinisch Genetisches Zentrum München - München, Germany |
Leukodystrophy / Leukencephalopathy Panel
method(s): ◦ Sequencing, Next Gen
CeGaT GmbH - Tübingen, Germany |
Migraine Panel
method(s): ◦ Sequencing, Next Gen
CeGaT GmbH - Tübingen, Germany |
Frontotemporal Dementia (FTD) Panel
method(s): ◦ Repeat Expansion / Contraction ◦ Sequencing, Next Gen
CeGaT GmbH - Tübingen, Germany |
Dementia all Panel
method(s): ◦ Del/Dup (CNV) ◦ Repeat Expansion / Contraction ◦ Sequencing, Next Gen
CeGaT GmbH - Tübingen, Germany |
Leukodystrophy / Leukencephalopathy and Differential Diagnoses Panel
method(s): ◦ Sequencing, Next Gen
CeGaT GmbH - Tübingen, Germany |
Small Vessel Disease Panel
method(s): ◦ Sequencing, Next Gen
CeGaT GmbH - Tübingen, Germany |
Somatic Tumor Panel
method(s): ◦ Sequencing, Next Gen
CeGaT GmbH - Tübingen, Germany |
Single gene testing NOTCH3
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger)
CeGaT GmbH - Tübingen, Germany |
Leukodystrophies, Panel Massive Sequencing (NGS) 58 genes
method(s): ◦ Sequencing, Next Gen
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
TAT: 2-4 weeks
price: $990.00
Lateral meningocele syndrome (LMS)
method(s): ◦ Sequencing, Next Gen
Connective Tissue Gene Tests - Allentown, PA, USA |
TAT: 7-10 days
price: $350.00
Lateral meningocele syndrome (LMS) Exon 33 Only
method(s): ◦ Sequencing, Capillary (Sanger)
Connective Tissue Gene Tests - Allentown, PA, USA |
TAT: 2-3 weeks
price: $680.00
Lateral meningocele syndrome (LMS)
method(s): ◦ Del/Dup (CNV)
Connective Tissue Gene Tests - Allentown, PA, USA |
TAT: 1-2 weeks
price: $1,570.00
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy (CADASIL)
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Connective Tissue Gene Tests - Allentown, PA, USA |
TAT: 2-3 weeks
price: $680.00
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy (CADASIL)
method(s): ◦ Del/Dup (CNV)
Connective Tissue Gene Tests - Allentown, PA, USA |
Comprehensive Neurogenetics Panel (290 genes)
method(s): ◦ Sequencing, Next Gen
Sherbrooke Genomic Medicine - Sherbrooke, Canada |
CADASIL Test
method(s): ◦ Del/Dup (CNV)
bio.logis Center for Human Genetics - Frankfurt am Main, Germany |
TAT: 2-4 weeks
price: $1,570.00
Lateral meningocele syndrome (LMS)
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Connective Tissue Gene Tests - Allentown, PA, USA |
CADASIL Test
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger)
GMDL Genica - Sofia, Bulgaria |
Epilepsy Exome Panel
method(s): ◦ Sequencing, Next Gen
University of Chicago, Genetic Services Laboratory - Chicago, IL, USA |
Comprehensive Dementia (NextGen Sequencing Panel and Copy Number Analysis; 91 genes)
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
MNG Laboratories (Medical Neurogenetics, LLC.) - Atlanta, GA, USA |
Comprehensive Dementia (NextGen Sequencing Panel, Copy Number Analysis, and C9orf72 Repeat Expansion Analysis; 91 genes)
method(s): ◦ Del/Dup (CNV) ◦ Repeat Expansion / Contraction ◦ Sequencing, Next Gen
MNG Laboratories (Medical Neurogenetics, LLC.) - Atlanta, GA, USA |
Comprehensive Epilepsy (NextGen Sequencing Panel and Copy Number Analysis; 502 genes + mtDNA)
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
MNG Laboratories (Medical Neurogenetics, LLC.) - Atlanta, GA, USA |
Comprehensive Leukodystrophy/Leukoencephalopathy (NextGen Sequencing Panel and Copy Number Analysis; 104 Genes + mtDNA)
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
MNG Laboratories (Medical Neurogenetics, LLC.) - Atlanta, GA, USA |
Non-Mitochondrial Leukodystrophy/Leukoencephalopathy (NextGen Sequencing Panel and Copy Number Analysis; 53 genes)
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
MNG Laboratories (Medical Neurogenetics, LLC.) - Atlanta, GA, USA |
Vanishing White Matter, Dysmyelinating, and Hypomyelinating Leukodystrophy (NextGen Sequencing Panel and Copy Number Analysis; 62 genes)
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
MNG Laboratories (Medical Neurogenetics, LLC.) - Atlanta, GA, USA |
Hemiplegia / Stroke NGS Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen
Fulgent Diagnostics - Temple City, CA, USA |
Leukoencephalopathy NGS Panel
method(s): ◦ Sequencing, Next Gen ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV)
Fulgent Diagnostics - Temple City, CA, USA |
NOTCH3
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen
Fulgent Diagnostics - Temple City, CA, USA |
Infantile myofibromatosis 2 (sequence analysis of NOTCH3 gene)
method(s): ◦ Sequencing, Next Gen
CGC Genetics - Porto, Portugal |
CADASIL: NOTCH3 gene
method(s): ◦ Sequencing, Capillary (Sanger)
GenoMed-Diagnosticos de Medicina Molecular, SA - Lisboa, Portugal |
TAT: 1-2 weeks
price: $1,350.00
Lateral meningocele syndrome (LMS) Exons 1-32 Only
method(s): ◦ Sequencing, Capillary (Sanger)
Connective Tissue Gene Tests - Allentown, PA, USA |
Comprehensive Epilepsy Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen
Fulgent Diagnostics - Temple City, CA, USA |
TAT: 3-5 weeks
price: $990.00
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) via the NOTCH3 Gene
method(s): ◦ Sequencing, Next Gen
PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
Leukoencephalopathy (Leukenzephalopathie)
method(s): ◦ Sequencing, Next Gen
Praxis fuer Humangenetik Wien - Vienna, Austria |
CADASIL /CARASIL (CADASIL /CARASIL)
method(s): ◦ Sequencing, Next Gen
Praxis fuer Humangenetik Wien - Vienna, Austria |
Metachromatic Leukodystrophy (Metachromatische Leukodystrophie)
method(s): ◦ Sequencing, Next Gen
Praxis fuer Humangenetik Wien - Vienna, Austria |
Migraine, familial (Migräne familiäre)
method(s): ◦ Sequencing, Next Gen
Praxis fuer Humangenetik Wien - Vienna, Austria |
Adult onset dementia and psychosis
method(s): ◦ Sequencing, Next Gen
Sherbrooke Genomic Medicine - Sherbrooke, Canada |
CADASIL
method(s): ◦ Sequencing, Capillary (Sanger)
Centogene AG, Rare Disease Company - Rostock, Germany |
Comprehensive Dementia (NextGen Sequencing Panel, Copy Number Analysis, and HTT Repeat Expansion Analysis; 91 genes)
method(s): ◦ Del/Dup (CNV) ◦ Repeat Expansion / Contraction ◦ Sequencing, Next Gen
MNG Laboratories (Medical Neurogenetics, LLC.) - Atlanta, GA, USA |
Comprehensive Dementia (NextGen Sequencing Panel, Copy Number Analysis, and C9orf72 + HTT Repeat Expansion Analysis; 91 genes)
method(s): ◦ Del/Dup (CNV) ◦ Repeat Expansion / Contraction ◦ Sequencing, Next Gen
MNG Laboratories (Medical Neurogenetics, LLC.) - Atlanta, GA, USA |
TAT: 3-5 weeks
price: $1,390.00
Infantile Myofibromatosis Sequencing Panel
method(s): ◦ Sequencing, Next Gen
PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
Migraine Spotlight Panel
method(s): ◦ Sequencing, Next Gen
Courtagen Life Sciences, Courtagen Diagnostics Laboratory - Woburn, MA, USA |
NGS panel - dementia/ALS
method(s): ◦ Del/Dup (CNV) ◦ Repeat Expansion / Contraction ◦ Sequencing, Next Gen
VU University Medical Center, Genome Diagnostics Amsterdam - Amsterdam, Netherlands |
Leukodystrophy and peroxisome biogenesis disorders panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Centogene AG, Rare Disease Company - Rostock, Germany |
Comprehensive Epilepsy Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Blueprint Genetics, Helsinki - Helsinki, Finland |
Leukodystrophy and Leukoencephalopathy Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Blueprint Genetics, Helsinki - Helsinki, Finland |
Migraine Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Blueprint Genetics, Helsinki - Helsinki, Finland |
Comprehensive Epilepsy Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Blueprint Genetics, San Francisco - San Francisco, CA, USA |
Leukodystrophy and Leukoencephalopathy Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Blueprint Genetics, San Francisco - San Francisco, CA, USA |
Migraine Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Blueprint Genetics, San Francisco - San Francisco, CA, USA |
Stroke (NextGen Sequencing Panel and Copy Number Analysis; 29 Genes + mtDNA)
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
MNG Laboratories (Medical Neurogenetics, LLC.) - Atlanta, GA, USA |
